Project Number EUJPND-CIHR-Multiple PI-425 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2016 View Full Project Details for Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology d. Brain Lipid Metabolism Researcher and Organization Principal Investigator Multiple PI Principal Investigator First Name Multiple PI Principal Investigator Last Name Multiple PI Awardee Organization University of Ottawa Contact PI Country Canada Project Detail FY Overall Cost $104,513 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
